文献速递慢性静脉疾病

氰基丙烯酸酯消融与射频消融治疗慢性大隐静脉功能不全的疗效与安全性比较:系统评价与荟萃分析

Efficacy and safety of cyanoacrylate ablation vs endovenous radiofrequency ablation for varicose veins in chronic great saphenous vein insufficiency: A systematic review and meta-analysis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-03-20

该系统评价与荟萃分析纳入21项研究、7844例患者共9677条肢体,比较氰基丙烯酸酯消融(CA)与腔内射频消融(RFA)治疗慢性大隐静脉(GSV)功能不全的疗效与安全性。结果显示两组GSV闭合率与静脉临床严重程度评分(VCSS)无显著差异,CA组瘀斑和感觉异常发生率更低、手术时间更短。

要点

  • CA与RFA在GSV闭合率和VCSS上疗效相当。
  • CA组瘀斑(5.96% vs 10.97%,P=.01)和感觉异常(1.24% vs 2.97%,P=.04)发生率更低。
  • CA组手术时间显著短于RFA组(P<.001)。

核心结论

  • 对于大隐静脉功能不全,CA的疗效与RFA相当,且瘀斑和皮肤色素沉着发生率更低、手术时间更短。

研究设计与样本

  • 遵循PRISMA指南的系统评价与荟萃分析,检索PubMed、Embase、Cochrane Library和Web of Science,纳入随机对照试验、队列研究和病例对照研究。
  • 共纳入21项研究,涵盖7844例患者和9677条肢体,由两名评价者独立提取数据并评估质量,使用Review Manager 5.3进行统计分析。

主要发现

  • CA与RFA在GSV闭合率或VCSS方面无显著差异。
  • CA组瘀斑发生率低于RFA组(5.96% vs 10.97%;P = .01)。
  • CA组感觉异常发生率低于RFA组(1.24% vs 2.97%;P = .04)。
  • 两组静脉炎、深静脉血栓(DVT)或色素沉着发生率无显著差异。
  • CA组手术时间显著短于RFA组(P < .001)。

临床怎么用

  • 对于慢性大隐静脉功能不全,CA可作为与RFA疗效相当的替代选择,尤其适合关注术后瘀斑、感觉异常或手术时间的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovenous radiofrequency ablation (RFA) and cyanoacrylate ablation (CA) are widely used for the treatment of chronic great saphenous vein (GSV) insufficiency. Compared with traditional surgery, both modalities have demonstrated well-recognized therapeutic benefits. However, controversy remains regarding the optimal choice between RFA and CA. The aim of this study was to conduct a systematic review and meta-analysis to compare the early and mid-term clinical outcomes of RFA vs CA. METHODS: A systematic review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Comprehensive searches were conducted in PubMed, Embase, Cochrane Library, and Web of Science to identify relevant studies. Randomized controlled trials, cohort studies, and case-control studies evaluating RFA and CA for the treatment of GSV incompetence were included. The primary outcomes were GSV occlusion rate and Venous Clinical Severity Score (VCSS). Secondary outcomes included skin pigmentation, phlebitis, deep vein thrombosis (DVT), ecchymosis, and procedure-related phlebitis. Data extraction and quality assessment were independently performed by two reviewers. Statistical analyses were conducted using Review Manager 5.3. RESULTS: A total of 21 studies were included, encompassing 7844 patients and 9677 limbs. In terms of efficacy, there were no significant differences between CA and RFA in GSV occlusion rate or VCSS. Regarding safety, pooled data showed that CA was associated with a lower incidence of ecchymosis (5.96% vs 10.97%; P = .01) and paresthesia (1.24% vs 2.97%; P = .04). No significant differences were observed between the two groups in the incidence of phlebitis, DVT, or pigmentation. In addition, the procedure time was significantly shorter in the CA group than in the RFA group (P < .001). CONCLUSIONS: For the treatment of incompetent saphenous veins, CA provides comparable efficacy to RFA. However, CA is associated with lower rates of skin pigmentation and ecchymosis, as well as a shorter procedure time.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Wen X, Wu H, He Y, et al. Efficacy and safety of cyanoacrylate ablation vs endovenous radiofrequency ablation for varicose veins in chronic great saphenous vein insufficiency: A systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41866115. doi:10.1016/j.jvsv.2026.102490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。